McMahon Gerald PhD 4
4 · Celldex Therapeutics, Inc. · Filed Sep 5, 2018
Insider Transaction Report
Form 4
McMahon Gerald PhD
Director
Transactions
- Tax Payment
Common Stock, par value $0.001
2018-09-04$0.50/sh−2,813$1,412→ 189,297 total
Footnotes (2)
- [F1]On November 28, 2016, in connection with the Reporting Person's employment severance agreement with Kolltan Pharmaceuticals, Inc., Reporting Person entered into a severance agreement (the "Severance Agreement") with Celldex Therapeutics, Inc. ("Issuer") whereby Issuer agreed to pay Reporting Person 267,356 shares of its common stock, par value $0.001 per share ("Common Stock") less required tax and other withholdings (the "Withholdings".) The Reporting Person previously reported ownership of such 267,356 shares on his Form 3 filed with the Securities and Exchange Commission on December 15, 2016. The shares, less Withholdings, are issuable to Reporting Person in equal installments through December 2018.
- [F2]Pursuant to the Severance Agreement, On September 4, 2018, the Issuer issued 5,541 shares of its Common Stock to the Reporting Person. This Form 4 reflects the disposition to the Issuer of 2,813 shares of its Common Stock to satisfy required Withholdings in connection with such issuance of Common Stock to the Reporting Person.